1. Home
  2. URG vs CBLL Comparison

URG vs CBLL Comparison

Compare URG & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ur Energy Inc (Canada)

URG

Ur Energy Inc (Canada)

HOLD

Current Price

$1.65

Market Cap

699.3M

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$18.25

Market Cap

750.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
URG
CBLL
Founded
2004
2014
Country
United States
United States
Employees
N/A
280
Industry
Precious Metals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
699.3M
750.1M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
URG
CBLL
Price
$1.65
$18.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$2.57
$23.20
AVG Volume (30 Days)
10.9M
319.7K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,207,000.00
N/A
Revenue This Year
$200.42
$29.57
Revenue Next Year
$98.46
$28.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$10.85
52 Week High
$2.35
$24.33

Technical Indicators

Market Signals
Indicator
URG
CBLL
Relative Strength Index (RSI) 47.86 47.80
Support Level $1.65 $17.17
Resistance Level $1.67 $19.67
Average True Range (ATR) 0.15 0.78
MACD 0.02 0.05
Stochastic Oscillator 31.43 65.86

Price Performance

Historical Comparison
URG
CBLL

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: